Theravance - THRX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theravance - THRX

THRX 9.810

+0.4%

Jan 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tnsaf	1/15/2008 7:56:19 PM
	of 74

Theravance to Offer $150M Worth of Notes Tuesday January 15, 5:21 pm ET Theravance Plans to Offer $150 Million Worth of Senior Notes Due 2015 SOUTH SAN FRANCISCO, Calif. (AP) -- Biotech drug maker Theravance Inc. said Tuesday it plans to offer $150 million worth of unsecured notes due in 2015. The company said it plans to grant underwriters a 30-day option to purchase an additional $22.5 million in notes. Merrill Lynch & Co., Goldman, Sachs & Co. will act as joint book-running managers for the offering. Shares of Theravance Inc. fell $1.66, or 7.7 percent, Tuesday to $20.02 in after hours trading, following an earlier close at $21.68.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next